Diffusely impaired myocardial perfusion in patients with suspected coronary artery disease: Clinical utility of relative perfusion
Niklas Vartiainen,
Antti‐Pekka E. Rissanen,
Suvi Hartikainen,
Svantte Halttunen,
Aleksi J. Leikas,
Elina Kariniemi,
Eero Strengell,
Paavo‐Ilari Kuikka,
Juha E. K. Hartikainen,
Tomi P. Laitinen Clinical Physiology and Functional Imaging
· Wiley
· 2026-09-30
· DOI: 10.1111/cpf.70096
The publisher did not provide an abstract — full text is available via the link below.
Niklas Vartiainen, Antti‐Pekka E. Rissanen, Suvi Hartikainen, Svantte Halttunen, Aleksi J. Leikas, Elina Kariniemi et al. Diffusely impaired myocardial perfusion in patients with suspected coronary artery disease: Clinical utility of relative perfusion. // Clinical Physiology and Functional Imaging. – 2026. – DOI: 10.1111/cpf.70096. – URL: https://onlinelibrary.wiley.com/doi/10.1111/cpf.70096?af=R
Niklas Vartiainen, Antti‐Pekka E. Rissanen, Suvi Hartikainen, Svantte Halttunen, Aleksi J. Leikas, Elina Kariniemi, Eero Strengell, Paavo‐Ilari Kuikka, Juha E. K. Hartikainen, & Tomi P. Laitinen (2026). Diffusely impaired myocardial perfusion in patients with suspected coronary artery disease: Clinical utility of relative perfusion. Clinical Physiology and Functional Imaging. https://doi.org/10.1111/cpf.70096
Niklas Vartiainen, et al. “Diffusely impaired myocardial perfusion in patients with suspected coronary artery disease: Clinical utility of relative perfusion.” Clinical Physiology and Functional Imaging, 2026. doi:10.1111/cpf.70096.
@article{Vartiainen2026,
title = {Diffusely impaired myocardial perfusion in patients with suspected coronary artery disease: Clinical utility of relative perfusion},
author = {Vartiainen, Niklas and Rissanen, Antti‐Pekka E. and Hartikainen, Suvi and Halttunen, Svantte and Leikas, Aleksi J. and Kariniemi, Elina and Strengell, Eero and Kuikka, Paavo‐Ilari and Hartikainen, Juha E. K. and Laitinen, Tomi P.},
journal = {Clinical Physiology and Functional Imaging},
year = {2026},
doi = {10.1111/cpf.70096},
url = {https://onlinelibrary.wiley.com/doi/10.1111/cpf.70096?af=R}
}
ABSTRACT Introduction/Aims Pompe disease is a genetic myopathy caused by acid alpha‐glucosidase enzyme deficiency. Treatment response is mainly evaluated using motor scores, for instance the 6‐min walk test (6MWT) or the Motor Function...
ABSTRACT Introduction/Aims Inflammatory neuropathies (IN), such as Guillain‐Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), are characterized by peripheral nerve injury driven by immune...